chr19-58477764-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017908.4(ZNF446):c.470A>T(p.Glu157Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000515 in 1,611,036 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017908.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF446 | NM_017908.4 | c.470A>T | p.Glu157Val | missense_variant | 3/7 | ENST00000594369.6 | NP_060378.1 | |
ZNF446 | NM_001304453.1 | c.470A>T | p.Glu157Val | missense_variant | 2/6 | NP_001291382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF446 | ENST00000594369.6 | c.470A>T | p.Glu157Val | missense_variant | 3/7 | 1 | NM_017908.4 | ENSP00000472802.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000812 AC: 20AN: 246434Hom.: 1 AF XY: 0.000135 AC XY: 18AN XY: 133300
GnomAD4 exome AF: 0.0000542 AC: 79AN: 1458756Hom.: 3 Cov.: 31 AF XY: 0.0000841 AC XY: 61AN XY: 725674
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.470A>T (p.E157V) alteration is located in exon 3 (coding exon 2) of the ZNF446 gene. This alteration results from a A to T substitution at nucleotide position 470, causing the glutamic acid (E) at amino acid position 157 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at